Overview

A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

Status:
Completed

Trial end date:
2024-05-13

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and pharmacokinetics of SHR-1314 injection in healthy subjects at different specifications devices.

Phase:

Phase 1

Details

Lead Sponsor:

Suzhou Suncadia Biopharmaceuticals Co., Ltd.